Yale Smilow Cancer Hospital — New Haven, Connecticut

Yale Smilow Cancer Hospital is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Yale Smilow Cancer Hospital has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: T-Cell Lymphoma, Solid Tumor, HER-2 Protein Overexpression.

Sponsors: Yale University, Cogent Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale Smilow Cancer Hospital?

Yale Smilow Cancer Hospital has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale Smilow Cancer Hospital conducted?

Yale Smilow Cancer Hospital has 2 clinical trials on record, with 1 currently active. Their work covers T-Cell Lymphoma, Solid Tumor, HER-2 Protein Overexpression.

Is Yale Smilow Cancer Hospital accredited by Crixeo Health?

Yale Smilow Cancer Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale Smilow Cancer Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.